More than half of people interested in taking the medication in Canada said having insurance coverage or lower-cost generic options would affect their decision
When discussing with her how some patients are not eligible to join a trial, she stated I would want to know why I did not qualify, but that would not prevent me from trying to get in another trial. Fortunately for Latasha and all of our participants, ENCORE Research Group is very transparent about the screening process and explains exactly why they may have been ineligible
In this type of anemia, people lack intrinsic factor in stomach which is necessary for the absorption of vitamin
262-OR: Pemvidutide, a GLP-1/glucagon dual receptor agonist, in subjects with overweight or obesitya 48-week, placebo-controlled, phase 2 (MOMENTUM) trial
Sayem et al., 2018)
We see a similar pattern with valproate, which has liver risks but improves liver health when used to reduce drinking in alcohol use disorder